Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03719417 · ClinicalTrials.gov registry record · NA
A Biologic Joint Replacement Strategy for Knee Trauma and Post-Traumatic Osteoarthritis
A NA study, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT03719417 is a NA study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 14 participants.
The verdict
NCT03719417, a NA study, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
Participants will be enrolled in a prospective clinical trial to assess outcomes in 2 cohorts of patients undergoing unicompartmental versus more extensive biologic OCA transplantation of the knee using MOPSTM-preserved allografts (including menisci), anatomically-shaped allografts, autogenous bone marrow aspirate concentrate (BMC)-treated donor bone, and treatment-specific postoperative rehabilitation.
Interventions
- PROCEDURE Unicompartmental Biologic Arthroplasty
- PROCEDURE Extensive Biologic Arthroplasty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2018-12-01 |
| Est. Completion | 2022-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03719417
The ClinicalTrials.gov registry entry for NCT03719417 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Unicompartmental Biologic Arthroplasty is the first listed.
NCT03719417 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03719417 about?
NCT03719417 is a clinical study titled "A Biologic Joint Replacement Strategy for Knee Trauma and Post-Traumatic Osteoarthritis". Participants will be enrolled in a prospective clinical trial to assess outcomes in 2 cohorts of patients undergoing unicompartmental versus more extensive biologic OCA transplantation of the knee using MOPSTM-preserved allografts (including menisci), anatomically-shaped allografts, autogenous bone ...
What is the current status of trial NCT03719417?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2018-12-01. Estimated completion is 2022-10-31.
What interventions are being tested in trial NCT03719417?
The interventions under investigation include: Unicompartmental Biologic Arthroplasty (PROCEDURE), Extensive Biologic Arthroplasty (PROCEDURE).
Who is sponsoring clinical trial NCT03719417?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.